Clinical References
Ambrosone, C. B., J. L. Freudenheim, et al. (1999). "Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer." Cancer Res 59(3): 602-6.
Bailey, L.B., J.F. Gregory . (1999)."Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement." J Nutr 129(5): 919-22
Bailey, L.B., J.F. Gregory. (1999). "Folate metabolism and requirements." J Nutr 129(4): 779-82
Borgstahl, G. E., H. E. Parge, et al. (1996). "Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface." Biochemistry 35(14): 4287-97.
Bosron, W.F., L. Ting-Kai (1986). "Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism." Hepatology 6(3): 502 - 510
Chango, A., F. Boisson, et al. (2000). "The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects." Br J Nutr 83(6): 593-6.
Cheng, T., Z. Zhu et al. (2001). "Effects of multinutrient supplementation on antioxidant defense systems in healthy human beings." J Nutr Biochem 12(7): 388-395.
Chistyakov, D. A., Savost'anov, et al. (2001). "Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus." BMC Med Genet 2(1): 4.
Cosma, G., F. Crofts, et al. (1993). "Relationship between genotype and function of the human CYP1A1 gene." J Toxicol Environ Health 40(2-3): 309-16.
Crabb, D. W., H. J. Edenberg, et al. (1989). "Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant." J Clin Invest 83(1): 314-6.
Crofts, F., E. Taioli, et al. (1994). "Functional significance of different human CYP1A1 genotypes." Carcinogenesis 15(12): 2961-3.
Cronin K A, Krebs-Smith S M, Feuer E J, Troiano R P, Ballard-Barbash R. (2001 May). "Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States)". Cancer Causes Control 12(4):305-16.
Dekou, V., P. Whincup, et al. (2001). "The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study." Atherosclerosis 154(3): 659-66.
Department of Health, London; Stationary Office (2000). Committee on Medical Aspects of Food and Nutrition Policy. Folic acid and the prevention of disease.
Fennell, T. R., J. P. MacNeela, et al. (2000). "Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes." Cancer Epidemiol Biomarkers Prev 9(7): 705-12.
Fohr I.O., R. Prinz-Lnagenohl, et al. (2002). "10-Methyleneterahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women." American Journal of Clinical Nutrition 75: 275 - 82
Fontana, R. J., K. S. Lown, et al. (1999). "Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P- glycoprotein levels in healthy volunteers." Gastroenterology 117(1): 89-98.
Fowke JH, Longcope C, Hebert JR. (2000) "Brassica Vegetable Consumption Shifts Estrogen Metabolism in Healthy Postmenopausal Women." Cancer Epidemiol Biomarkers Prev 9(8):773-779.
Gao, X., T. Albena, Dinkova-Kostova, P. Talalay (2001). "Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: The indirect antioxidant effects of sulforaphane." PNAS 98(26): 15221 - 15226.
Getahun SM, Chung FL.. (1999). "Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress." Cancer Epidemiology Biomarkers Preview 8(5): 447 - 451.
Giovannucci, E. (1999). "Nutritional factors in human cancers." Adv Exp Med Biol 472: 29-42.
Giovannucci, E. M.J. Stampfer, et al. (1998). "Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study." Annals of Internal Medicine 129: 517 - 524
Guyonnet, D., Belloir, C., Suschetet, M., Siess, M.H., Le Bon, A.M. (2001) Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. Mut Res 496(1-2)135-142
Harada, S., D. P. Agarwal, et al. (2001). "Metabolic and ethnic determinants of alcohol drinking habits and vulnerability to alcohol-related disorder." Alcohol Clin Exp Res 25(5 Suppl ISBRA): 71S-75S.
Inoue, K., T. Asao, et al. (2000). "Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations." Xenobiotica 30(3): 285-95.1.
Jacques, P. F., A. G. Bostom, et al. (1996). "Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations." Circulation 93(1): 7-9.
Kang, Z. C., S. J. Tsai, et al. (1999). "Quercetin inhibits benzo[a]pyrene-induced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 gene expression." Nutr Cancer 35(2): 175-9.
Lampe, J.W., C.Chen et al. (2000). "Modulation of human glutathione S-transferases by botanically defined vegetable diets." Cancer Epidemiology Biomarkers Preview 9(8):787-93.
Landi, S. (2000). "Mammalian class theta GST and differential susceptibility to carcinogens: a review." Mutat Res 463(3): 247-83.
Lanza, E; Schatzkin, A, Daston, C, Corle, D; Freedman, L, Ballard-Barbash, R, Caan, B, Lance, P, Marshall, J, Iber, F, Shike, M, Weissfeld, J, Slattery, M, Paskett, E, Mateski, D, Albert, P, and the PPT Study Group (2001). "Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial 1, 2" Am J Clin Nutr 74:387-401
Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, Frankl HD, Lee ER, Haile RW. (1998 Aug). "Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas." Cancer Epidemiol Biomarkers Prev 7(8):647-52.
London, S. J., J. M. Yuan, et al. (2000). "Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China." Lancet 356(9231): 724-9.
Lutz, W. K. (1999). "Carcinogens in the diet vs overnutrition. Individual dietary habits, malnutrition, and genetic susceptibility modify carcinogenic potency and cancer risk." Mutation Research 443: 251-258
Michaud DS, Spiegelman D, et al..(1999). "Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort." J Natl Cancer Inst 91(7): 605-13.
Miller MC 3rd, Mohrenweiser HW, Bell DA. (2001) "Genetic variability in susceptibility and response to toxicants." Toxicol Lett 120(1-3):269-80
Nijhoff, W.A., T.P. Mulder et al. (1995). "Effects of consumption of brussels sprouts on plasma and urinary glutathione S-transferase class-alpha and -pi in humans." Carcinogenesis 16(4): 955-7.
Parke, D.V. (1999). "Antioxidants and disease prevention: mechanisms of action". Antioxidants in Human Health. CABI Publishing.
Perera, F. P. and I. B. Weinstein (2000). "Molecular epidemiology: recent advances and future directions." Carcinogenesis 21(3): 517-24.
Rozen, R. (2000). "Genetic modulation of homocysteinemia." Semin Thromb Hemost 26(3): 255-61.
Sandhu MS, White IR, McPherson K. (2001). "Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach." Cancer Epidemiol Biomarkers Prev 10(5): 439-46
Schuppe HC, Wieneke P, Donat S, Fritsche E, Kohn FM, Abel J. (2000). "Xenobiotic metabolism, genetic polymorphisms and male infertility." Andrologia 32(4-5): 255-62
Sinha R, Chow WH, Kulldorff M, Denobile J, Butler J, Garcia-Closas M, Weil R, Hoover RN, Rothman N. (1999). "Well-done, grilled red meat increases the risk of colorectal adenomas." Cancer Res 59(17): 4320-4
Smith TJ, Yang CS. (2000).Effect of organosulfur compounds from garlic and cruciferous vegetables on drug metabolism enzymes." Drug Metabol Drug Interact 17(1-4):23-49
Spiteri, M. A., A. Bianco, et al. (2000). "Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation." Allergy 55(Suppl 61): 15-20.
Steinkellner H, Rabot S, Freywald C, Nobis E, Scharf G, Chabicovsky M, Knasmuller S, Kassie F. (2001). "Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens." Mutat Res 480-481: 285-97
Strange, R. C., M. A. Spiteri, et al. (2001). "Glutathione-S-transferase family of enzymes." Mutat Res 482(1-2): 21-6.
Sunder-Plassmann, G., M. Fodinger, et al. (2000). "Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study." J Am Soc Nephrol 11(6): 1106-16.
Takeshita, T. and K. Morimoto (2000). "Accumulation of hemoglobin-associated acetaldehyde with habitual alcohol drinking in the atypical ALDH2 genotype." Alcohol Clin Exp Res 24(1): 1-7.
Ueland, P. M., S. Hustad, et al. (2001). "Biological and clinical implications of the MTHFR C677T polymorphism." Trends Pharmacol Sci 22(4): 195-201.
Vakevainen S, Tillonen J, Agarwal DP, Srivastava N, Salaspuro M. (2000). "High salivary acetaldehyde after a moderate dose of alcohol in ALDH2-deficient subjects: strong evidence for the local carcinogenic action of acetaldehyde." Alcohol Clin Exp Res 22(4): 195-201
Van Iersel, M.L., H. Verhagen et al. (1999). "The role of biotransformation in dietary (anti)carcinogenesis." Mutation Research 443(1-2): 259-70.
Van Landeghem, G. F., P. Tabatabaie, et al. (1999). "Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD." Hum Hered 49(4): 190-3.
Verhoeff, B. J., M. D. Trip, et al. (1998). "The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis." Atherosclerosis 141(1): 161-6.
Wang, X., B. Zuckerman, et al. (2002) "Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight." Journal of the American Medical Association 287(2): 195 - 202
Willett WC. (1995). "Diet, nutrition, and avoidable cancer". Environ Health Perspect 103(Suppl 8): 165-170
Williams JA, Martin FL, Muir GH, Hewer A, Grover PL, Phillips DH. (2000). "Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue." Carcinogenesis 21(9): 1683-9.
Yamauchi M, Takeda K, Sakamoto K, Searashi Y, Uetake S, Kenichi And H, Toda G. (2001). "Association of polymorphism in the alcohol dehydrogenase 2 gene with alcohol-induced testicular atrophy." Alcohol Clin Exp Res 25( Suppl 6): 16-8
Yokoyama A, Muramatsu T, Ohmori T, Yokoyama T, Okuyama K, Takahashi H, Hasegawa Y, Higuchi S, Maruyama K, Shirakura K, Ishii H. (1998). "Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics." Carcinogenesis 19(8):1383-7
Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Yu MC, Lee HP. (2001). "Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore." Cancer Epidemiol Biomarkers Prev 10(10): 1063-7
Zusterzeel PL, Nelen WL, Roelofs HM, Peters WH, Blom HJ, Steegers EA. (2000). "Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss." Mol Hum Reprod 6(5): 474-8
Molecular Model. National Human Genome Research Institute, National Institutes of Health. Oct. 24, 2007. http://www.genome.gov/11511419
Polymorphisms. Kimball’s Biology Pages. (An Online Biology Textbook.) Sept. 19, 2007. http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/P/Polymorphisms.html
What are single nucleotide polymorphisms (SNPs)? Genetics Home Reference. A service of the U.S. National Library of Medicine. Jan. 7, 2008. http://ghr.nlm.nih.gov/handbook/genomicresearch/snp
What are single nucleotide polymorphisms (SNPs)? Genetics Home Reference. A service of the U.S. National Library of Medicine. Jan. 7, 2008. http://ghr.nlm.nih.gov/handbook/genomicresearch/snp
Mammone T, et al. A water soluble extract from Uncaria tomentosa (Cat’s Claw) is a potent enhancer of DNA repair in primary organ cultures of human skin. Phytother Res. 2006 Mar;20(3):178-83.
Akesson C, et al. An extract of Uncaria tomentosa inhibiting cell division and NF-kappa B activity without inducing cell death. Int Immunopharmacol. 2003 Dec;3(13-14):1889-900.
Sheng Y, et al. DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. Phytomedicine. 2001 Jul;8(4):275-82.
Sheng Y, et al. Enhanced DNA repair, immune function and reduced toxicity of C-MED-100, a novel aqueous extract from Uncaria tomentosa. J Ethnopharmacol. 2000 Feb;69(2):115-26.
Frank, BS. Nucleic Acid Therapy in Aging and Degenerative Disease—A Metabolic Approach with DNA, RNA and Related Metabolites. New York, Psychological Library Publishers, 1968.
Morrison NA et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367(6460):284-7.
Thakkinstan A et al. Haplotype analysis of VDR gene polymorphisms: a meta-analysis. Osteoporos Int. 2004;15(9):729-34.
Thakkinstan A et al. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 2004;19(3):419-28.
Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases.Clin Chim Acta. 2006 Sep;371(1-2):1-12.
D’Alesio A et al. Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum Mol Genet. 2005;14(22):3539-48.
Marco MP et al. Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. Am J Kidney Dis. 2001;38(5):965-74.
Dawson-Hughes B et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670-6.
Knapen et al. 2007. Vitamin K(2) supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18(7):963-72.
Shiraki M et al. 2000. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15:515-21.
Schurgers, L.J., et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007 Apr 15;109(8):3279-83. Epub 2006 Dec 7.
Morisseau C and BD Hammock. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol. 2005;45:311-33
Hecht SS. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism, J. Nutr. 1999;129:768S–774S.
Higdon JV. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res. 2007;55(3):224-36.
Minich DM and JS Bland. A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals. Nutr Rev. 2007;65(6 Pt 1):259-67.
Naik R et al. A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. Int J Gynecol Cancer. 2006;16:786-790.
Wong GY et al. Dose-ranging study of indole-3-carbinol for breast caner prevention. J Cell Biochem Suppl. 1997;28-29:111-116.
Verhoeven DT et al. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev. 1996;5(9):733-48.
Bradlow HL et al. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev. 1994;3:591-595.
Hosoe K et al. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007;47(1):19-28.
Ross D et al. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact. 2000 Dec 1;129(1-2):77-97.
Hosoe K et al. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007;47(1):19-28.
Hinson BH. The role of manganese superoxide dismutase in health and disease. J Inherit Metab Dis 1998;21:598–603.
Bandy B and AJ Davison. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med 1990;8:523–39.
Burton KP. Superoxide dismutase enhances recovery following myocardial ischemia. Am J Physiol Heart Circ Physiol 1985; 248:H637-H643.
HEALTH & WEALTH MANUAL “Nourishing Human Potential” 49
Younes M et al. Inhibition of lipid peroxidation by superoxide dismutase following regional intestinal ischemia and reperfusion. Res Exp Medi 1987;187(1):9-17.
Greenberger JS and MW Epperly. Review. Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization. In Vivo. 2007;21(2):141-6.
Wu et al. Antioxidant activities of some common ingredients of traditional Chinese medicine Angelica sinensis, Lycium barbarum and Poria cocus. Phytother Res. 2004;18:1008-1012.
Ha KT et al. Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol. 2005;96(3):529-35.
Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005 Nov;64(4):527-42.
Hu YJ and AM Diamond. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003;63(12):3347-51.
Huu Y et al. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 2005;135(12 Suppl):3021S-3024S.
Ratnasinghe D et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 2000 Nov 15;60(22):6381-3.
Moscow J. A., Schmidt L., Ingram D. T., Gnarra J., Johnson B., Cowan K. H. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis (Lond.), 15: 2769-2773, 1994.
Clark LC et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J Am Med Assoc. 1996;276:1957-1963.
Yu SY et al. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 1997;56:117-124.
Yu SY et al. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 1997;56:117-124.
Knekt P et al. Is low selenium status a risk factor for lung cancer? Am J Epidemiol. 1998;148:975-982.
Yoshizawa K et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998;90:1219-1224.
Ghadirian P et al. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev. 2000;24:305-313.
Lippman SM et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97:94-102.
Cunnane G et al. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis Rheum. 2001;44:2263–2274.
Dörr S et al. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther. 2004;6(3):R199-207.
Ikeda Y. et al. 2006. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study. J Nutr. 136(5):1323-8.
Martin KR. The chemistry of silica and its potential health effects. J Nutr Health Aging. 2007;11(2):94-7.
Kobayashi T et al. Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis. Inflamm Res. 2005 Jun;54(6):249-55.
Campo GM et al. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures. Cell Biol Int. 2006;30(1):21-30.
Martensson J, Larsson J and Nordstrom H. Amino acid metabolism during the anabolic phase of severely burned patients: with special reference to sulphur amino acids. Eur J Clin Invest. 17:130-135, 1987
Usha PR and MU Naidu. Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis. Clin Drug Investig. 2004;24(6):353-63.
Kalman DS et al. A randomized double blind clinical pilot trial evaluating the safety and efficacy of hydrolyzed collagen type II in adults with osteoarthritis. FASEB Experimental Biology 2004 Abstracts, Washington DC, April 17-21, 2004; A90.
Refsum H et al. Homocysteine and Cardiovascular Disease. Ann Rev Med. 1998;49:31-62.
Eikelboom J et al. Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiological Evidence. Ann Intern Med. 1999;131:363-375.
Kankey G et al. Homocysteine and Vascular Disease. Lancet. 1999;354 (9176): 407-413.
Frosst P et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10:111–113.
Jacques PF et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93: 7–9.
Gaughan DJ et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 2001;157(2):451-6. 50 HEALTH & WEALTH MANUAL “Nourishing Human Potential”
Guéant-Rodriguez RM et al. Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population. Thromb Haemost. 2005;94(3):510-5.
Barbosa PR et al. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur J Clin Nutr. 2007 May 23 [Epub ahead of print]
Ubbink JB et al. Vitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans. J Nutr. 1994;124:1927-1933.
Lobo A et al. Reduction of Homocysteine Levels in Coronary Artery Disease by Low-Dose Folic Acid Combined With Vitamins B6 and B12. Am J Cardiol. 83:821-825, 1999.
Dierkes J et al. Folic Acid and Vitamin B6 Supplementation and Plasma Homocysteine Concentrations in Healthy Young Women. Intl J Vit Nutr Res. 1996;68:98-103.
Brouwer I et al. Low-Dose Folic Acid Supplementation Decreases Plasma Homocysteine Concentrations: A Randomized Trial. Am J Clin Nutr. 1999;69:99-104.
Homocysteine Lowering Trialists’ Collaboration: Lowering Blood Homocysteine With Folic Acid Based Supplements: Meta Analysis of Randomized Trials. Brit J Med. 1998;316(7135):894-8.
McNulty H, McKinley MC, Wilson B, Mc Partlin J, Strain JJ, Weir DG, Scott JM. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr. 2002; 76: 436–44Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem. 2000; 46: 1065–1071.
Lee et al. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol. 2007;34(1):43-9.
Alvarez V et al. Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease. Am J Med Genet. 2002;114(5):574-7.
Witte JS et al. Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet. 2002;10(1):82-
Elahi MM et al. A variant of position -308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart disease. Heart Lung Circ. 2007 Jun 18; [Epub ahead of print]
Roy S et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells.DNA Cell Biol. 2005;24(4):244-55.
Roy S, Khanna S, Krishnaraju AV, et al. Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia. Antioxid Redox Signal. 2006;8(3-4):653-60.
Safayhi et al. Boswellic acids: novel, specific, non-redox inhibitors of 5-lipoxygenase. J Pharm Exp Ther. 1992;261(3):1143-1146.
Wildfeuer et al. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. AzneimForsch/Drug Res. 1984;48:668-674.
Ammon et al. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med. 1991;57:203-207.
Singh et al. Anti-inflammatory actions of boswellic acids. Phytomedicine. 3(1):81-85, 1996.
Sharma et al. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol. 11(6):647-652, 1989.
Kimmatkar N. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3-7.
Peng Q et al. Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells. Cell Mol Life Sci. 2000;57(5):834-41.
Byun CH et al. Alpha-lipoic acid inhibits TNF-alpha-induced apoptosis in human bone marrow stromal cells. J Bone Miner Res. 2005;20(7):1125-35.
Tastekin N. Protective effects of l-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res. 2007 Aug 3 [Epub ahead of print]
Aviram M et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest. 1998;101:1581-1590.
Garin et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest. 1997;99(1):62-6.
Humbert R et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet. 1993;3:73-76.
Robertson KS et al. Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II. Biochim Biophys Acta. 2003;1639(3):203-12.
Voetsch B et al. The Combined Effect of Paraoxonase Promoter and Coding Region Polymorphisms on the Risk of Arterial Ischemic Stroke Among Young Adults. Arch Neurol. 2004;61(3):351-356.
Aviram M et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 23(3):423-33, 2004.HEALTH & WEALTH MANUAL “Nourishing Human Potential” 51
Aviram et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res. 2002;28(2-3):49-62.
Aviram M et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000;71(5):1062-76.
Gouedard C. Induction of the paraoxonase-1 gene expression by resveratrol. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2378-83.
Curtin BF et al. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines. J Cell Biochem. 2007 Sep 19 [Epub ahead of print]
Rosenblat M et al. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis. 2006;187(2):363-71.
Sumner MD et al. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol. 2005;96(6):810-4.
Bradamante S. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 2004;22(3):169-88.
Tlitalo et al. Baroreflex sensitivity and variants of the renin-angiotensin system genes. J Am Coll Cardiol. 2000;35(1):194-200.
Hautanen A et al. Joint Effects of an Aldosterone Synthase (CYP11B2) Gene Polymorphism and Classic Risk Factors on Risk of Myocardial Infarction. Circulation. 1999;100:2213.
Wexler R and G Aukerman. Nonpharmacologic strategies for managing hypertension. Am Fam Physician. 2006;73(11):1953-6.
King DE, et al. Dietary Magnesium and C-reactive Protein Levels. J Am Coll Nutr. 2005 Jun;24(3):166-71.
Napoli C et al. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006;15(4):265-79.
Benn M et al. Polymorphism in APOB Associated with Increased Low-Density Lipoprotein Levels in Both Genders in the General Population. J Clin Endocrinol Met. 2005;90(10):5797-5803.
Talmud PJ et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis. 1987;67:81–89.
Law A et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1986;1:1301–1303.
Hegele RA et al. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med. 1986;315:1509–1515.
Bentzen J et al. Further studies of the influence of apolipoprotein B alleles on glucose and lipid metabolism. Hum Biol. 2003;75(5):687-703.
Moreno-Luna R et al. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population. J Clin Endocrinol Metab. 2007;92(6):2280-5.
Balk EM et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189(1):19-30.
Pearce BC et al. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem. 1992;35(20):3595-606.
Qureshi AA et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids. 1995;30(12):1171-7.
Qureshi AA et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr. 1991;53(4 Suppl):1021S-1026S.
Qureshi AA et al. Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem. 2001;12(6):318-329.
Suzuki YJ et al. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry. 1993;32(40):10692–10699.
Mortensen SA, et al. Long-term coenzyme Q10 therapy in patients with congestive heart failure: a major advance in the management of resistant myocardial failure. Drug Exptl Clin Res. 1985;11:581-93.
Polymorphisms. Kimball’s Biology Pages. (An Online Biology Textbook.) Sept. 19, 2007. http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/P/Polymorphisms.html
What are single nucleotide polymorphisms (SNPs)? Genetics Home Reference. A service of the U.S. National Library of Medicine. Jan. 7, 2008. http://ghr.nlm.nih.gov/handbook/genomicresearch/snp
What are single nucleotide polymorphisms (SNPs)? Genetics Home Reference. A service of the U.S. National Library of Medicine. Jan. 7, 2008. http://ghr.nlm.nih.gov/handbook/genomicresearch/snp
